Antirheumatic Therapy: Actions and Outcomes
Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Y...
| Corporate Author: | |
|---|---|
| Other Authors: | , , , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Basel :
Birkhäuser Basel,
2005.
|
| Series: | Progress in Inflammation Research
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Table of Contents:
- Medicinal chemistry of the disease modifying anti-rheumatic drugs
- Targeting DMARD therapy
- Pharmacoeconomic properties of disease-modifying antirheumatic drugs
- Future molecular targets
- Hydroxychloroquine
- Sulfasalazine
- Parenteral gold
- Azathioprine
- Methotrexate
- Leflunomide
- Cyclosporin
- Tetracyclines
- Systemic glucocorticoids in rheumatoid arthritis
- TNF-? inhibitors
- Anakinra in rheumatoid arthritis
- Combination therapy
- Hematopoietic stem cell transplantation for the treatment of severe autoimmune diseases.